244 related articles for article (PubMed ID: 28776170)
1. Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
Radocha J; Paterová P; Zavřelová A; Víšek B; Gabalec F; Žemličková H; Žák P
Folia Microbiol (Praha); 2018 Mar; 63(2):141-146. PubMed ID: 28776170
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
[TBL] [Abstract][Full Text] [Related]
3. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children.
Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
BMC Infect Dis; 2013 Jun; 13():273. PubMed ID: 23773209
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility.
Shargian L; Paul M; Nachshon T; Ayada G; Nesher L; Raanani P; Ben-Zvi H; Henig O; Yahav D
Eur J Clin Microbiol Infect Dis; 2023 Feb; 42(2):177-182. PubMed ID: 36502498
[TBL] [Abstract][Full Text] [Related]
6. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
7. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
Presterl E; Grisold AJ; Reichmann S; Hirschl AM; Georgopoulos A; Graninger W
J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519
[TBL] [Abstract][Full Text] [Related]
8. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
Maeda Y; Elborn JS; Parkins MD; Reihill J; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Ennis M; Rendall JC; Moore JE
J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
[TBL] [Abstract][Full Text] [Related]
9. Emerging Resistance Trends in Viridans Group Streptococci Bloodstream Infections Among Immunocompromised Children Receiving Levofloxacin Prophylaxis.
Quintero AM; Cruz Vidal DA; Klamer BG; Ardura MI; Oyeniran SJ
J Pediatric Infect Dis Soc; 2023 Jul; 12(7):381-391. PubMed ID: 37490409
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
11. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population.
Rozkiewicz D; Daniluk T; Sciepuk M; Zaremba ML; Cylwik-Rokicka D; Luczaj-Cepowicz E; Milewska R; Marczuk-Kolada G; Stokowska W
Adv Med Sci; 2006; 51 Suppl 1():191-5. PubMed ID: 17460837
[TBL] [Abstract][Full Text] [Related]
12. Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases.
Ergin A; Eser ÖK; Hasçelik G
New Microbiol; 2011 Apr; 34(2):187-93. PubMed ID: 21617831
[TBL] [Abstract][Full Text] [Related]
13. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance.
Bruckner L; Gigliotti F
Semin Pediatr Infect Dis; 2006 Jul; 17(3):153-60. PubMed ID: 16934710
[TBL] [Abstract][Full Text] [Related]
14. [Identification and antibiotic susceptibility of viridans group streptococci isolates recovered from patients hospitalized at a teaching hospital in Buenos Aires City].
Heine AC; García S; Barberis C; Vay C; E Mollerach M; Bonofiglio L; Famiglietti Á
Rev Argent Microbiol; 2019; 51(1):26-31. PubMed ID: 29941157
[TBL] [Abstract][Full Text] [Related]
15. Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital.
Nielsen MJ; Claxton S; Pizer B; Lane S; Cooke RPD; Paulus S; Carrol ED
Medicine (Baltimore); 2016 Mar; 95(9):e2952. PubMed ID: 26945409
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological and clinical characteristics of Streptococcus tigurinus endocarditis.
Ercibengoa M; Goenaga MA; Ardanuy C; Grau I; García-de-la-Maria C; Almela M; Miro JM; Navas E; Fariñas MC; de Alegría CR; de la Torre J; Fernández F; Marín M; Muñoz P; Orden B; Oteo JA; García-Álvarez L; de Alarcón A; Jiménez JAL; Marimón JM
BMC Infect Dis; 2019 Mar; 19(1):291. PubMed ID: 30922322
[TBL] [Abstract][Full Text] [Related]
17. In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices.
Paulus S; Dobson S; Rassekh S; Blondel-Hill E
J Pediatr Hematol Oncol; 2009 Apr; 31(4):267-9. PubMed ID: 19346878
[TBL] [Abstract][Full Text] [Related]
18. Species-specific difference in antimicrobial susceptibility among viridans group streptococci.
Chun S; Huh HJ; Lee NY
Ann Lab Med; 2015 Mar; 35(2):205-11. PubMed ID: 25729722
[TBL] [Abstract][Full Text] [Related]
19. Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group.
Lewis V; Yanofsky R; Mitchell D; Dix D; Ethier MC; Gillmeister B; Johnston D; Michon B; Stobart K; Portwine C; Silva M; Cellot S; Price V; Bowes L; Zelcer S; Brossard J; Beyene J; Sung L
Pediatr Infect Dis J; 2014 Feb; 33(2):126-9. PubMed ID: 24064558
[TBL] [Abstract][Full Text] [Related]
20. [Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci].
Artiles Campelo F; Horcajada Herrera I; Alamo Antúnez I; Cãnas Pedrosa A; Lafarga Capuz B
Rev Esp Quimioter; 2007 Sep; 20(3):317-22. PubMed ID: 18080028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
